FDA Investigator Kelly D Moore

Kelly D Moore has conducted inspections on 362 sites in 11 countries as of 10 Sep 2020. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
362
Last Inspection Date:
10 Sep 2020
Investigator Role:
FDA Investigator
Redica ID:
100005793
Countries of Inspections:
United States of America, United Kingdom of Great Britain and Northern Ireland, Netherlands, Poland, Canada, Bulgaria, Germany, Finland, Italy, Denmark, Romania
FDA Investigators that have inspected at least one site in common with Kelly D Moore:
Alanna L Mussawwir Bias, Alexander M Kay, Amy A Johnson, Amy Johnson, Ana Djurdjevic, Andrea J Schmidt, Andrew M Kolenc, Barbara J Rincon, Barbara J White, Betty Kay Baxter, Brandon K Lawson, Brent W Higgs, Brittany R Laymon, Bryan Baker, Bryan J Love, Bryce A May, Carla R Hinz, Carmen Y Fisher, Carolyn J Cook, Christine I Shaw, Christine L Williams, Christopher J Freebairn, Cody D Rickman, Conor J Mccarron, Courtney R Bratina, Cynthia Jim, CSO, Dan G Eisenbrey, Daniel J Lahar, Daniel Pst Laurent, David L Miser, Dawn C Olenjack, Deborah S Hammond, Debra L Curtis, Denicia L Hernandez, Diana L Ayala, Diane Hall, Dianna D Wardlow Dotter, Dolores E Price, Dr. Gang Wang, PhD, Edward D Harris, Elaine G Stewart, Elisa J Beard, Emily B Camire, Emily S Mcgann, Eric S Myskowski, Eric T Huebler, Erma Zaimova, Farhana Khan, Frank L Cordova, Garrad R Poole, George J Flynn, Ginger M Sykes, Gloria A Milster, Gloria J Baca, MS, Grace E Mcnally, Hanna L Potter, Helen B Ricalde, Hoimay Chan, Holly L Miller, Ingrid Y Johnson, Iris C Macinnes, Isabel Y Espinosa, James R Montero, Jamie L Dion, Jennifer A Baker, Jennifer L Jager, Jennifer L Sheehan, Jennifer R Mathern, Jessica E Hensley, Jessie E Morris, Joan A Loreng, John A Iwen, Jonathan R Campos, Julia D Cartwright, Julian C Hanson, Justin R Carr, Kaarin M Slotte, Kathleen S Tormey, Kathryn A Krentz, Kellie L Thommes, RN, Kenneth S Boehnen, Kevin D Kallander, Kimberley A Hoefen, Kimberly A Peterson, Kristen E Szenderski, Larisa E Pavlick, Laura B Kennedy, Lauren R Howell, Laurissa S Flowers, Lavender M Huskey, LCDR Ismael Olvera, IV, Lesley Maep Lutao, Lillie M Young, Linda M Cheny, Lori A Carr, Lori A Gioia, Maira P Brading, Marc A Jackson, Jr, Margaret M Annes, Marie B Buen Bigornia, Marion D Wimberly, Jr, Marion Michaelis, Marion W Nadeau, Marsha L Mccauley, Martina E Lagrange, Mary F Bodick, Mary T Carden, Matthew J Gretkierewicz, Matthew M Vernon, Matthew R Dionne, Maurine Fadlalla, Melisa A Healy, Melissa J Nucci, Melsomar R Ramos, Michael A Blaine, Michael D Vansickle, Michael E Maselli, Michael J Kuchta, Michael L Zimmerman, Michael R Goga, Michele L Forster, PhD, Mitzi A Schwertfeger, Mohammad Heidaran, PhD, Nancy L Neiger, Nathan M Jornod, Nathan R Moon, Nayan J Patel, Nicholas M Smith, Omotunde O Osunsanmi, Patricia A Brown, Patricia A Maestas, Patricia M Jacobs, Paul L Dexter, Paul M Chefor, Peter Kessler, PhD, Randy V Bong, Rebecca T Davis, Richard L Bartlett, Richard L Rutherford, Richard T Riggie, Ricki A Chase, Robert J Nesselhauf, Roberta W Cunningham, Rocco C Black, Rose Ashley, Ruth A Williams, Scott T Ballard, Shelley H Beausoleil, Shererk, Srinivas R Chennamaneni, PhD, Stephen T Hansen, Steve P Yost, Steven C Madzo, Stuart W Russell, Sunitha K Rajaram, PhD, Tamara L Setzer, Teena H Aiken, Tenzin Jangchup, Theressa B Smith, Thomas V Anderson, Tonia L Sawyer, Travis S Bradley, Trevor R Beach, Tricia S Martinez, Vanessa R Muller, Vanessa Y Gelsey, PhD, Vanessa Y Jacobs, Verdell Nelson, Vickie J Kanion, Vicky L Cruz, Wayne W Grundstrom, William D Boden, William F Lagud, Jr, Zachary A Bogorad, Zachary L Miller, Zachary L Stamm

Kelly D Moore's Documents

Publish Date Document Type Title
June, 2013 FDA 483 CSL Plasma Inc. - Form 483, 2013-06-25
December, 2001 EIR Redbeast Enterprises Inc dba High Quality Research - EIR, 2001-12-18
May, 2008 FDA 483 American National Red Cross (The), Lewis and Clark Region - Form 483, 2008-05-23
January, 2015 FDA 483 Response CSL Plasma Inc. - Form 483R, 2015-02-12
January, 2015 FDA 483 CSL Plasma Inc. - Form 483, 2015-01-23
December, 2000 EIR Savage, Susan M.D. - EIR, 2000-12-14
August, 2019 FDA 483 DonorConnect - Form 483, 2019-08-20
June, 2013 EIR CSL Plasma Inc. - EIR, 2013-06-25
August, 2013 FDA 483 Nico de Vries, M.D. - Form 483, 2013-08-09
January, 2017 FDA 483 Presbyterian/St. Luke's Medical Center Donor Services - Form 483, 2017-01-26
January, 2015 EIR CSL Plasma Inc. - EIR, 2015-01-23
May, 2002 EIR Innovative Blood Resources d.b.a. Nebraska Community Blood Bank - EIR, 2002-05-21
December, 2000 FDA 483 Savage, Susan M.D. - Form 483, 2000-12-14
May, 2002 FDA 483 Innovative Blood Resources d.b.a. Nebraska Community Blood Bank - Form 483, 2002-05-21
April, 2016 FDA 483 Helle Merete Staugaard, M.D. - Form 483, 2016-04-08
July, 2018 FDA 483 PolarityTE, Inc - Form 483, 2018-07-13
January, 2017 FDA 483 Response Presbyterian/St. Luke's Medical Center Donor Services - Form 483R, 2017-02-06
August, 2013 FDA 483 Giulia V. Bianchi, M.D. - Form 483, 2013-08-02
April, 2009 FDA 483 Regenerative Sciences, LLC - Form 483, 2009-04-15
March, 2019 FDA 483 ARUP Laboratories Inc. - Form 483, 2019-03-14
June, 2013 FDA 483 Response CSL Plasma Inc. - Form 483R, 2013-07-16
April, 2019 FDA 483 LifeNet Health Northwest, LLC - Form 483, 2019-04-11
March, 2019 EIR ARUP Laboratories, Inc. - EIR, 2019-03-11
February, 2013 FDA 483 Grifols - Form 483, 2013-02-04
May, 2018 FDA 483 American National Red Cross (The), Lewis and Clark Region - Form 483, 2018-05-23
April, 2006 FDA 483 Goff, John S. - Form 483, 2006-04-20
November, 2002 FDA 483 StatLine - Form 483, 2002-11-18
June, 2010 FDA 483 Regenerative Sciences, LLC - Form 483, 2010-06-16
January, 2017 EIR Presbyterian/St. Luke's Medical Center Donor Services - EIR, 2017-01-26
May, 2019 FDA 483 VRL Eurofins - Form 483, 2019-05-17
June, 2009 FDA 483 Lesh, Kurt, M.D. - Form 483, 2009-06-02
November, 2008 FDA 483 CryoGam Colorado, LLC. - Form 483, 2008-12-02
July, 2018 EIR PolarityTE, Inc - EIR, 2018-07-13
July, 2018 FDA 483 University of Utah Cell Therapy Facility - Form 483, 2018-07-13
July, 2014 FDA 483 Orovan, William, M.D. - Form 483, 2014-08-18
February, 2013 EIR Grifols - EIR, 2013-02-04
June, 2009 EIR Lesh, Kurt, M.D. - EIR, 2009-06-02

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more